Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Common Stock to be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021	$ 19,747	$ 12,068	$ 13,976,159	$ (14,129,625)	$ (121,651)
Beginning balance, shares at Dec. 31, 2021	19,747,283	12,067,458
Common stock issued from common stock to be issued	$ 11,441	$ (11,441)
Common stock issued for common stock to be issued, shares	11,441,177	(11,441,177)
Stock-based compensation expense			1,081		1,081
Net loss				(167,047)	(167,047)
Ending balance, value at Mar. 31, 2022	$ 31,188	$ 627	13,977,240	(14,296,672)	(287,617)
Ending balance, shares at Mar. 31, 2022	31,188,460	626,281
Beginning balance, value at Dec. 31, 2021	$ 19,747	$ 12,068	13,976,159	(14,129,625)	(121,651)
Beginning balance, shares at Dec. 31, 2021	19,747,283	12,067,458
Net loss					(492,185)
Ending balance, value at Sep. 30, 2022	$ 31,188	$ 727	14,073,164	(14,480,276)	(520,278)
Ending balance, shares at Sep. 30, 2022	31,188,460	726,281
Beginning balance, value at Mar. 31, 2022	$ 31,188	$ 627	13,977,240	(14,296,672)	(287,617)
Beginning balance, shares at Mar. 31, 2022	31,188,460	626,281
Stock-based compensation expense			1,081		1,081
Net loss				(180,056)	(180,056)
Ending balance, value at Jun. 30, 2022	$ 31,188	$ 627	13,978,321	(14,476,728)	(466,592)
Ending balance, shares at Jun. 30, 2022	31,188,460	626,281
Stock-based compensation expense			41,395		41,395
Net loss					(145,081)
Adjustment of expiration date on certain warrants			3,548	(3,548)
Common stock issued from warrant exercise		$ 100	49,900		50,000
Common stock issued from warrant exercise, shares		100,000
Ending balance, value at Sep. 30, 2022	$ 31,188	$ 727	14,073,164	(14,480,276)	(520,278)
Ending balance, shares at Sep. 30, 2022	31,188,460	726,281
Beginning balance, value at Dec. 31, 2022	$ 31,188	$ 727	14,131,709	(15,117,963)	(950,791)
Beginning balance, shares at Dec. 31, 2022	31,188,460	727,281
Stock-based compensation expense			20,697		20,697
Net loss				(211,277)	(211,277)
Ending balance, value at Mar. 31, 2023	$ 31,188	$ 727	14,152,406	(15,325,692)	(1,144,919)
Ending balance, shares at Mar. 31, 2023	31,188,460	727,281
Beginning balance, value at Dec. 31, 2022	$ 31,188	$ 727	14,131,709	(15,117,963)	(950,791)
Beginning balance, shares at Dec. 31, 2022	31,188,460	727,281
Net loss					(587,309)
Ending balance, value at Sep. 30, 2023	$ 32,071	$ (0)	14,335,776	(15,701,725)	(1,333,878)
Ending balance, shares at Sep. 30, 2023	32,071,299
Beginning balance, value at Mar. 31, 2023	$ 31,188	$ 727	14,152,406	(15,325,692)	(1,144,919)
Beginning balance, shares at Mar. 31, 2023	31,188,460	727,281
Net loss				(135,693)	(135,693)
Common stock to be issued pursuant to private placement completed in April 2023		$ 400	99,600		100,000
Common stock to be issued pursuant to private placement completed in April 2023, shares		400,000
Common stock to be issued per loan commitment		$ 329	83,197		83,526
Common stock to be issued per loan commitment, shares		328,571
Ending balance, value at Jun. 30, 2023	$ 31,188	$ 1,456	14,335,203	(15,461,385)	(1,093,538)
Ending balance, shares at Jun. 30, 2023	31,188,460	1,455,852
Common stock issued from common stock to be issued	$ 883	$ (829)	(54)
Common stock issued for common stock to be issued, shares	882,839	(828,571)
Net loss				(240,340)	(240,340)
Common stock cancelled from common stock to be issued		$ (627)	627
Stock issued during period shares common stock cancelled fom common stock to be issued		(627,281)
Ending balance, value at Sep. 30, 2023	$ 32,071	$ (0)	$ 14,335,776	$ (15,701,725)	$ (1,333,878)
Ending balance, shares at Sep. 30, 2023	32,071,299